Trial Profile
A Retrospective,cohort study to evaluate the efficacy and safety of Sofosbuvir based regimens in patients with genotype 4 Chronic Hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Sofosbuvir (Primary) ; Peginterferon; Ribavirin; Simeprevir
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 20 Jan 2017 New trial record